4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18245691 | SINGLE-DOMAIN ANTIBODY TARGETING 4-1BB, FUSION PROTEIN THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Mar 16, 2023 |
| 18245694 | ANTI-4-1BB-ANTI-PD-L1 BISPECIFIC ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | AEDER, SEAN E | 1642 | Non-Final OA | Mar 16, 2023 |
| 17995287 | PLATFORM FOR CONSTRUCTING MULTISPECIFIC ANTIBODY | CUNNINGCHEN, KATHLEEN MARY | 1646 | Non-Final OA | Sep 30, 2022 |
| 17596183 | Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof | BERHANE, SELAM | 1675 | Non-Final OA | Dec 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial